BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Long Q, Flanders WD, Bostick RM, Yuan Y. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study. Int J Cancer. 2014; Jun 4. [Epub ahead of print]. [PMID: 24895149 DOI: 10.1002/ijc.29005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Rugge M. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication. Gastroenterology Clinics of North America 2015;44:609-24. [DOI: 10.1016/j.gtc.2015.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
2 Tu H, Sun L, Dong X, Gong Y, Xu Q, Jing J, Bostick RM, Wu X, Yuan Y. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study. Am J Gastroenterol. 2017;112:704-715. [PMID: 28323271 DOI: 10.1038/ajg.2017.55] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
3 Wang BG, Li YZ, Ding HX, Lv Z, Xu Q, Yuan Y. HOTTIP polymorphism may affect gastric cancer susceptibility by altering HOTTIP expression. Biosci Rep 2020;40:BSR20191687. [PMID: 32725141 DOI: 10.1042/BSR20191687] [Reference Citation Analysis]
4 Xie JB, Wan J, Zhang H, Liu YL, Zhang LH, Mao JL, Zhang SS. Clinical significance of serum pepsinogens in screening of gastric cancer and gastric ulcer. Shijie Huaren Xiaohua Zazhi 2014; 22(31): 4820-4824 [DOI: 10.11569/wcjd.v22.i31.4820] [Reference Citation Analysis]
5 Wang BG, Ding HX, Lv Z, Xu Q, Yuan Y. Interaction of HULC polymorphisms with Helicobacter pylori infection plays a strong role for the prediction of gastric cancer risk. Future Oncol 2020;16:1997-2006. [PMID: 32941073 DOI: 10.2217/fon-2020-0228] [Reference Citation Analysis]
6 Wang Z, Lv Z, Ding H, Xu Q, Sun L, Jing J, Yuan Y. Role of serum EBV-VCA IgG detection in assessing gastric cancer risk and prognosis in Northern Chinese population. Cancer Med 2018;7:5760-74. [PMID: 30306734 DOI: 10.1002/cam4.1792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Su X, Ye Z, Wang Z, Long Y, Qiu M, He C. Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer. Virus Res 2018;256:1-5. [PMID: 30053417 DOI: 10.1016/j.virusres.2018.07.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Jiang J, Shen S, Dong N, Liu J, Xu Q, Sun L, Yuan Y. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases. Cancer Med 2018;7:4068-76. [PMID: 29963765 DOI: 10.1002/cam4.1615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
9 Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016;65:721-725. [PMID: 26927528 DOI: 10.1136/gutjnl-2015-310846] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
10 Loor A, Dumitraşcu DL. Helicobacter pylori Infection, Gastric Cancer and Gastropanel. Rom J Intern Med 2016;54:151-6. [PMID: 27658162 DOI: 10.1515/rjim-2016-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
11 Gan J, Cheng RG, Wang SF. Diagnostic value of serum pepsinogen in gastric diseases. Shijie Huaren Xiaohua Zazhi 2018; 26(36): 2115-2119 [DOI: 10.11569/wcjd.v26.i36.2115] [Reference Citation Analysis]
12 Fang J, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, Lv NH, Chen YX, Lv B; Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on chronic gastritis (2017, Shanghai): 2017 Chinese consensus on CG. Journal of Digestive Diseases 2018;19:182-203. [DOI: 10.1111/1751-2980.12593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sun L, Tu H, Chen T, Yuan Q, Liu J, Dong N, Yuan Y. Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer. Sci Rep 2017;7:11621. [PMID: 28912586 DOI: 10.1038/s41598-017-12022-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
14 Gao X, Jia Y, Xu H, Li Y, Zhu Q, Wei C, Hou J, Li D, Wang W, Li Z, Guo R, Jia J, Wu Y, Wei Z, Qi X, Li Y. Association between serum pepsinogen and atherosclerotic cardiovascular disease. Nutr Metab Cardiovasc Dis 2021;31:169-77. [PMID: 33127250 DOI: 10.1016/j.numecd.2020.07.045] [Reference Citation Analysis]
15 Lv Z, Sun L, Xu Q, Gong Y, Jing J, Xing C, Yuan Y. Long non-coding RNA polymorphisms in 6p21.1 are associated with atrophic gastritis risk and gastric cancer prognosis. Oncotarget 2017;8:95303-15. [PMID: 29221129 DOI: 10.18632/oncotarget.20115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
16 Liu S, Liu JW, Sun LP, Gong YH, Xu Q, Jing JJ, Yuan Y. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018;46:5155-5166. [PMID: 30205739 DOI: 10.1177/0300060518792785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46:657-667. [PMID: 28782119 DOI: 10.1111/apt.14248] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 10.6] [Reference Citation Analysis]
18 Zhang JG, Xu C, Zhang L, Zhu W, Shen H, Deng HW. Identify gene expression pattern change at transcriptional and post-transcriptional levels. Transcription 2019;10:137-46. [PMID: 30696368 DOI: 10.1080/21541264.2019.1575159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Wu YF, Xu Q, He CY, Li Y, Liu JW, Deng N, Sun LP, Yuan Y. Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer. Sci Rep 2017;7:39528. [PMID: 28067243 DOI: 10.1038/srep39528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
20 Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir. Int J Mol Sci 2016;17:E891. [PMID: 27275821 DOI: 10.3390/ijms17060891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
21 Xu Q, Chen TJ, He CY, Sun LP, Liu JW, Yuan Y. MiR-27a rs895819 is involved in increased atrophic gastritis risk, improved gastric cancer prognosis and negative interaction with Helicobacter pylori. Sci Rep 2017;7:41307. [PMID: 28150722 DOI: 10.1038/srep41307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
22 Shen S, Jiang J, Yuan Y. Pepsinogen C expression, regulation and its relationship with cancer. Cancer Cell Int 2017;17:57. [PMID: 28546787 DOI: 10.1186/s12935-017-0426-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lv Z, Sun L, Xu Q, Gong Y, Jing J, Dong N, Xing C, Yuan Y. SNP interactions of PGC with its neighbor lncRNAs enhance the susceptibility to gastric cancer/atrophic gastritis and influence the expression of involved molecules. Cancer Med. 2018;7:5252-5271. [PMID: 30155999 DOI: 10.1002/cam4.1743] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
24 Lee SP, Lee SY, Kim JH, Sung IK, Park HS, Shim CS. Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings. J Korean Med Sci 2017;32:796-802. [PMID: 28378553 DOI: 10.3346/jkms.2017.32.5.796] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhang QY, Lv Z, Sun LP, Dong NN, Xing CZ, Yuan Y. Clinical significance of serum markers reflecting gastric function and H. pylori infection in colorectal cancer. J Cancer 2019;10:2229-36. [PMID: 31258726 DOI: 10.7150/jca.27134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ning P, Sun L, Dong N, Yuan Y. PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases. Chin J Cancer Res 2020;32:89-95. [PMID: 32194308 DOI: 10.21147/j.issn.1000-9604.2020.01.10] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Malla B, Aebersold DM, Dal Pra A. Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy. J Transl Med 2018;16:223. [PMID: 30103771 DOI: 10.1186/s12967-018-1592-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
28 Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective. Clin Endosc. 2014;47:478-489. [PMID: 25505712 DOI: 10.5946/ce.2014.47.6.478] [Cited by in Crossref: 68] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
29 Re V, Zorzi M, Caggiari L, Repetto O, Brisotto G, Magris R, Zanussi S, Steffan A, Cannizzaro R. Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients. Microorganisms 2021;9:126. [PMID: 33430456 DOI: 10.3390/microorganisms9010126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Chu A, Yu X, Guo Q, Li Q, Sun M, Yuan Y, Gong Y. H. pylori slyD, a novel virulence factor, is associated with Wnt pathway protein expression during gastric disease progression. Microb Pathog 2020;148:104428. [PMID: 32791303 DOI: 10.1016/j.micpath.2020.104428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]